Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - isosorbide mononitrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - isosorbide mononitrate, quantity: 60 mg - tablet, modified release - excipient ingredients: purified talc; titanium dioxide; lactose monohydrate; hypromellose; stearic acid; magnesium stearate; iron oxide yellow; macrogol 4000; carnauba wax; colloidal anhydrous silica - prophylactic treatment of angina pectoris. apo- isosorbide mononitrate 60mg sustained release tablets are not recommended for the management of acute attacks of angina pectoris (see precautions).

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - isosorbide mononitrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - isosorbide mononitrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - sodium cromoglycate, quantity: 5 mg - inhalation, pressurised - excipient ingredients: povidone; macrogol 600; apaflurane - the prophylactic treatment of bronchial asthma, including the prevention of exercise induced bronchospasm.

Australia - English - Department of Health (Therapeutic Goods Administration)

clinect pty ltd - isosorbide mononitrate, quantity: 120 mg - tablet, modified release - excipient ingredients: hyprolose; hypromellose; magnesium stearate; titanium dioxide; colloidal anhydrous silica; synthetic paraffin; aluminium sodium silicate; macrogol 6000 - indications as at 08 may 2001 : monodur durules are indicated for prophylactic treatment of angina pectoris. monodur durules are not recommended for the management of acute attacks of angina pectoris (see precautions).

Australia - English - Department of Health (Therapeutic Goods Administration)

clinect pty ltd - isosorbide mononitrate, quantity: 120 mg - tablet, modified release - excipient ingredients: hypromellose; colloidal anhydrous silica; synthetic paraffin; hyprolose; magnesium stearate; titanium dioxide; macrogol 6000; aluminium sodium silicate - indications as at 08 may 2001 : imdur durules are indicated for prophylactic treatment of angina pectoris. imdur durules are not recommended for the management of acute attacks of angina pectoris (see precautions).

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - formoterol fumarate dihydrate, quantity: 4.5 microgram/actuation - inhalation, powder for - excipient ingredients: lactose monohydrate - long-term treatment of reversible airways obstruction in asthma (including nocturnal asthma and exercise induced asthma) in adults and children aged 12 years and over and who are receiving inhaled or oral corticosteroids and who require bronchodilator therapy.,oxis turbuhaler can be used on demand (prn) in asthmatics over the age of 18 years who are receiving inhaled or oral corticosteroids. it should not be used in patients whose asthma can be managed alone by occasional use of short acting inhaled beta-2 agonists.

Australia - English - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - formoterol fumarate dihydrate, quantity: 9 microgram/actuation - inhalation, powder for - excipient ingredients: lactose monohydrate - long-term treatment of reversible airways obstruction in asthma (including nocturnal asthma and exercise induced asthma) in adults and children aged 12 years and over and who are receiving inhaled or oral corticosteroids and who require bronchodilator therapy.,oxis turbuhaler can be used on demand (prn) in asthmatics over the age of 18 years who are receiving inhaled or oral corticosteroids. it should not be used in patients whose asthma can be managed alone by occasional use of short acting inhaled beta-2 agonists.

Australia - English - Department of Health (Therapeutic Goods Administration)

clinect pty ltd - isosorbide mononitrate, quantity: 60 mg - tablet, modified release - excipient ingredients: titanium dioxide; macrogol 6000; magnesium stearate; colloidal anhydrous silica; aluminium sodium silicate; hypromellose; iron oxide yellow; synthetic paraffin; hyprolose - indications as at 08 may 2001: monodur is indicated for prophylactic treatment of angina pectoris. monodur is not recommended for the management of acute attacks of angina pectoris (see precautions).